entertainment -WSS

entertainment

author：Wikipedia 2025-10-03 00:47:33 - browse：8891

The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

“They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： TytoCare raises $49 million to build out AI

Wikipedia

WSS

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

ER docs worry over extreme heat as a 'mass casualty event'

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Excited delirium, Elijah McClain, and emergency physicians

Sanofi CEO defends move to abandon profit guidance, boost research

Abortion clinic in Cancun will cater to Americans

knowledge

entertainment

focus

Walensky prepares to leave CDC — and Congress — behind

Biden calls for immediate release of Niger's president amid apparent coup

Alkermes shareholders re

What Henrietta Lacks settlement says about racism in medicine

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

ER docs worry over extreme heat as a 'mass casualty event'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Free speech concerns arise in wake of journal editor Eisen's firing

Moonlake's readout produced a cash windfall. Risks remain

Biotech incubator Curie.Bio graduates its first startup

focus

For BCIs, commercial hurdles may be bigger than scientific ones

Study: New antibiotic targets gonorrhea as well as last existing drug

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

A clever new way to fix Medicaid and graduate medical education

'Ancient DNA,' 23andMe reveal African American ancestries

Biotech incubator Curie.Bio graduates its first startup

focus

leisure time

Wikipedia

hotspot